MOESM14 of Allogeneic stem-cell transplantation for multiple myeloma: a systematic review and meta-analysis from 2007 to 2017

Additional file 14: Figure S10. Sensitivity analysis diagram of progression-free survival (PFS) at 1 year (a), 2 years (b), 3 years (c),and 5 years (d)

MOESM9 of Allogeneic stem-cell transplantation for multiple myeloma: a systematic review and meta-analysis from 2007 to 2017

Additional file 9: Figure S5. Funnel plot of progression-free survival (PFS) at 1 year (a), 2 years (b), 3 years (c),and 5 years (d)

MOESM5 of Allogeneic stem-cell transplantation for multiple myeloma: a systematic review and meta-analysis from 2007 to 2017

Additional file 5: Figure S1. Forest plot of the subgroup overall survival (OS) benefit (auto-allo vs only-allo, auto-allo vs tandem auto, MA vs RIC, high-risk vs standard-risk, first-line vs salvage therapy) (a), (post-transplantation in CR vs in non-CR, at transplantation in CR vs in non-CR, over 50 vs under 50, PBSC vs BM, aGVHD vs non-aGVHD, cGVHD vs non-cGVHD) (b)

MOESM10 of Allogeneic stem-cell transplantation for multiple myeloma: a systematic review and meta-analysis from 2007 to 2017

Additional file 10: Figure S6. Funnel plot of treatment-related mortality (TRM) at 100 days (a), 1 year (b), 2 years (c), 3 years (d), and 5 years (e)

MOESM3 of Allogeneic stem-cell transplantation for multiple myeloma: a systematic review and meta-analysis from 2007 to 2017

Additional file 3: Table S3. Quality assessment of individual clinical trials

MOESM17 of Allogeneic stem-cell transplantation for multiple myeloma: a systematic review and meta-analysis from 2007 to 2017

Additional file 17: Figure S13. Sensitivity analysis diagram of relapse rate (a) and death (b)

MOESM15 of Allogeneic stem-cell transplantation for multiple myeloma: a systematic review and meta-analysis from 2007 to 2017

Additional file 15: Figure S11. Sensitivity analysis diagram of treatment-related mortality (TRM) at 100 days (a), 1 year (b), 2 years (c), 3 years (d),and 5 years (e)

MOESM12 of Allogeneic stem-cell transplantation for multiple myeloma: a systematic review and meta-analysis from 2007 to 2017

Additional file 12: Figure S8. Funnel plot of relapse rate (a) and death (b)

MOESM8 of Allogeneic stem-cell transplantation for multiple myeloma: a systematic review and meta-analysis from 2007 to 2017

Additional file 8: Figure S4. Funnel plot of overall survival (OS) at 1 year (a), 2 years (b), 3 years (c), and 5 years (d)